Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2412
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRakhi-
dc.date.accessioned2024-05-13T06:39:15Z-
dc.date.available2024-05-13T06:39:15Z-
dc.date.issued2022-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2412-
dc.language.isoen_USen_US
dc.publisherIIHMR Universityen_US
dc.subjectPharmaceuticalen_US
dc.subjectBrand Planen_US
dc.titleThe Market Research, Analysis & Brand Plan of a New Drug Triptorelin Acetate (GNRH Agonist) Being Launched for the Downregulation in IVF Treatmenten_US
dc.typeSummer Reporten_US
dc.guideChowhan, Sudhinder Singhen_US
dc.organizationnameINTAS Pharmaceuticals Limited, Gujaraten_US
Appears in Collections:2022

Files in This Item:
File Description SizeFormat 
Rakhi_ Intas Certificate.pdfCertificate222.13 kBAdobe PDF Preview PDFDownload
Rakhi_poster_0329 (5).pptxPoster882.91 kBMicrosoft Powerpoint XML Preview PDFDownload


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.